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Abstract
Background: Somatosensory evoked potentials (SSEP) are being used for the investigation and monitoring of the 
integrity of neural pathways during surgical procedures. Intraoperative neurophysiologic monitoring is affected by the 
type of anesthetic agents. Remifentanil is supposed to produce minimal or no changes in SSEP amplitude and latency. 
This study aims to investigate whether high doses of remifentanil influence the SSEP during spinal surgery under total 
intravenous anesthesia.
Methods: Ten patients underwent spinal surgery. Anesthesia was induced with propofol (2 mg/Kg), fentanyl (2 mcg/
Kg) and a single dose of cis-atracurium (0.15 mg/Kg), followed by infusion of 0.8 mcg/kg/min of remifentanil and 
propofol (30-50 mcg/kg/min). The depth of anesthesia was monitored by Bispectral Index (BIS) and an adequate level 
(40-50) of anesthesia was maintained. Somatosensory evoked potentials (SSEPs) were recorded intraoperatively from 
the tibial nerve (P37) 15 min before initiation of remifentanil infusion. Data were analysed over that period.
Results: Remifentanil induced prolongation of the tibial SSEP latency which however was not significant (p > 0.05). The 
suppression of the amplitude was significant (p < 0.001), varying from 20-80% with this decrease being time related.
Conclusion: Remifentanil in high doses induces significant changes in SSEP components that should be taken under 
consideration during intraoperative neuromonitoring.
Introduction
Electrophysiological monitoring is applied during spinal
surgery in order to assess the nervous tissue at risk for
injury in a patient who is unable to respond due to anes-
thesia. There are several tests that can be performed
intraoperatively to indicate a probable spinal injury; the
so-called "wake up" test is time consuming and can not be
performed at any time or in the emergency setting while
motor evoked potentials (MEPs) are extremely sensitive
to anesthetic agents. Somatosensory evoked potentials
(SSEP) measure the integrity of the sensory pathways in
the dorsal columns of the spinal cord, by stimulating a
peripheral sensory nerve and measuring the electrical
response in the brain. The introduction of SSEP monitor-
ing to spinal surgery has significantly reduced the rate of
intraoperative injury. A survey of the Scoliosis Research
Society and the European Spinal Deformities Society
documented a reduction in injury rate from 0.7-4.0% in
the pre-SSEP monitoring days to less than 0.55% with
SSEP monitoring [1].
SSEP are less affected by anesthetic agents than MEP
[ 2 ] .  T h e  d e p r e s s a n t  e f f e c t  o f  v o l a t i l e  a n e s t h e t i c s  o n
evoked potentials is well known [3-5]. Recent studies
consider total intravenous anesthesia (TIVA) with the
combination of propofol and fentanyl as more appropri-
ate for intraoperative neuromonitoring [4-10]. However,
intravenous anesthetics affect SSEPs as well, in a dose-
related fashion [5,7,8,10]. The effect of propofol on SSEPs
latency and amplitude has been already addressed.
Propofol produces from minimal to less than 10% sup-
pression of SSEP amplitude [1,5,7,8,10].
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Opioids are commonly used to supplement anesthetic
agents during neuromonitoring and are considered to
have only minimal effects on anesthetic-sensitive poten-
tials. Different doses of fentanyl have been noted to cause
prolonged amplitude depression [11,12].
Remifentanil is a newer short-acting opioid and its
pharmacokinetics and pharmacodynamic characteristics
make it unique for use in TIVA. It may also provide an
excellent adjunct in situations where muscle relaxation
must be avoided and minimal dosing of anesthetic agents
is required. Animal data suggest that remifentanil is less
suppressive than other opioids on MEPs but does not
affect the SSEP [13,14]. Recent studies in humans have
shown some dose-dependent reduction on the motor sys-
tem when remifentanil was used as a single agent but
there is not any published clinical trial of the effect of
remifentanil on SSEP during general anesthesia [15].
Patients undergoing spinal surgery usually experience
severe pain and large doses of opioids are administered
intraoperative in combination with other anesthetic
agents. Therefore it is essential to justify in which way the
SSEPs are affected by opioids so that clinicians can make
more informed interpretations of SEP changes. This
study was designed to evaluate the effect of remifentanil
on SSEP's latency and amplitude during propofol anes-
thesia in patients undergoing spinal surgery.
Materials and methods
In this prospective study, intraoperative data of 10 other-
wise healthy patients (mean age 42.2 ± 30.7) years, range
of 13-88 years (4 females and 6 males) were analyzed. The
procedures performed included surgery on the thoracic/
lumbar spine for scoliosis or stenosis with instrumenta-
tion.
Approval of the local ethics committee and written
informed consent were obtained. Patients with ASA
physical status > 2, Body Mass Index (BMI) over 30, indi-
cation for rapid sequence induction, recent administra-
tion of central nervous system affecting drugs, or
neurological or psychiatric diseases were excluded from
this investigation.
All patients received 0.1 mg/kg oral dose of diazepam
as premedication approximately 2 hours before surgery.
No other sedatives or centrally acting agents were given
before induction of anesthesia. Perioperative monitoring
included continuous electrocardiogram of five leads-
ECG, heart rate (HR), noninvasive and invasive (arterial
line) systolic, diastolic and mean arterial pressure (MAP),
end-tidal CO2, pulse oximeter probe (SpO2) oesophageal
temperature (Datex Ohmeda) and ourine output. Intra-
operative normothermia was actively maintained with a
forced air warming blanket. The depth of anesthesia was
monitored with the bispectral index (BIS) (target 40 to
50) through 4 skin electrodes placed in a 2-channel refer-
ential montage on patients' foreheads. All leads were con-
nected to an electroencephalographic monitor (Aspect
Medical System Inc, GR, Version 3.2).
Cardiac output (CO) was monitored through pulse
contour analysis, in order to ensure that CO is not signifi-
c a n t l y  i n f l u e n c e d  b y  t h e  h i g h  d o s e  o f  r e m i f e n t a n i l .  A
FloTracTM sensor kit (Edwards Lifesciences) was con-
nected to the arterial line and connected to the Vigile-
oTM monitor programmed with the 3.02 version (2009)
of the software for this device. Patient data (age, gender,
body weight, and height) were entered and after checking
the arterial line waveform fidelity, the system was zeroed
and cardiac output measurement initiated.
General anesthesia was induced with propofol (2 mg/
Kg), fentanyl (2 mcg/Kg) and cis-atracurium (0.15 mg/
Kg). After anesthesia induction the trachea was intu-
bated, and mechanical ventilation with intermittent posi-
tive pressure ventilation was started at a tidal volume of 7
mL/kg of IBW and with respiratory frequency adjusted to
maintain end-tidal CO2 between 30 and 35 mmHg in a
semi closed circuit with 2.0 L/min of fresh gas flow. The
lungs were ventilated with air/O2 mixture and ventilation
was adjusted to an EtCO2 tension of 30-35 mmHg, in
order to achieve mild vasoconstriction that minimizes
the blood loss and provides a better surgical field. Anes-
thesia was maintained with continuous intravenous infu-
sion of remifentanil and propofol (30-50 mcg/kg/min).
Use of neuromuscular block was avoided after intubation.
The dose of remifentanil (0.8 mcg/Kg/min) was chosen,
based on our previous clinical experience of the dose
(about 0.5-0.8 mcg/kg/min) that is usually required to
control the intraoperative pain stimulus.
Due to the fact that false positive readings and periop-
erative SSEP changes are elicited from factors such as
hypothermia, anemia, hypocapnia (PaCO2 < 30 mmHg)
or hypotension, the temperature was maintained over
36°C, the transfusion threshold at Hct < 30 mg/dl, and the
mean arterial pressure (MAP)≥60 mmHg with vasoactive
drugs (esmolol and ephedrine).
SSEP protocol
The evoked response is recorded as a plot of signal ampli-
tude (in mcV) versus latency (in msec), which is the time
elapsed from stimulus delivery to arrival of the impulse at
the recording electrode. An increase in the latency of 10%
and a decrease in amplitude of 50% are considered signif-
icant [16]. Such changes reflect loss of the integrity of the
neural pathway and a reason for intervention by the sur-
gical team. In case that changes of SSEP components
were over that limits, surgeons recheck the position of
instrumentation; if they were sure that these changes
were not due to their manipulations but due to anesthetic
agents the operation was continued.Asouhidou et al. Scoliosis 2010, 5:8
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Measurement of the SSEP was used to monitor the
function of the spinal cord throughout the operation.
Subdermal stainless steel needle electrodes were percuta-
neously placed for stimulating the peripheral nerves and
recording from the somatosensory cortical sites. Stimula-
tion of the posterior tibial nerve (P37) with supramaximal
constant-voltage single-pulse stimuli of 0.2 ms, at 20 per
second, was applied alternately to both legs. For intraop-
erative assessment, a total of 300 intraoperative SSEP
measurements from 10 patients were analyzed; a mean
average of 12 +/- 4 of each tibial nerve was performed per
operation. The SSEP amplitude was measured as the dif-
ference in microvolt (mcV) between the peak and trough
deflections. The latency was measured as the time
elapsed between stimulation and the first peak (msec).
The changes in the minimum stimulus intensity (that is,
threshold level) required to evoke elicit amplitude were
also evaluated. The recordings were stored on the com-
puter and were analyzed as a batch by an investigator
blinded to the treatment condition. All markers were set
by a single person to reduce variability.
Right after intubation continuous intravenous infusion
(civ) of propofol was initiated in order to maintain a BIS
value between 40-50. The patients were positioned on the
table in spine-prone position and the first measurement
of SSEP was done at that time; this first measurement was
considered the baseline SSEP (SSEPb). The first SSEP
measurement (SSEPb) was performed 30 minutes after
induction in anesthesia. This time is enough to wash out
the anesthetic agents administered to perform induction
in anesthesia. After the baseline measurement civ of
r e m i f e n t a n i l  i n  d o s e  o f  0 . 8  m c g / k g  w a s  i n i t i a t e d .  A s
remifentanil plasma concentration reaches a steady state
within 10 minutes of infusion, the second measurement
was taken 15 minutes after initiation of civ of remifentanil
(SSEPr).
Statistical analysis
Data were expressed as mean ± SD (in all cases n = num-
ber of patients) and were analyzed statistically using the
SPSS program package, version 16.0. Differences in cate-
gorical data were evaluated using the student t test. A
beta error level of 15% or statistical power of 85% and an
a-level of 0.05 was used to calculate the sample size of this
study. The p-level was set at 0.05.
Results
T en patients were included in the study and all of them
completed the study. Their demographic characteristics
are shown in Table 1. Satisfactory SSEPs were recorded in
all patients, allowing adequate monitoring at all times.
Despite the high doses of remifentanil that were used in
this study, we did not notice any episodes of bradycardia
or low cardiac output even though the mean arterial pres-
sure presented statistically significant difference (p =
0.005) (Table 2). All procedures were carried out without
any surgical or anesthesiologic complications.
Continuous intravenous infusion of remifentanil
induced significant suppression of SSEP amplitude (p =
0.001). The waves of P37 amplitude were strongly
reduced in comparison to baseline waves with adminis-
tration of remifentanil. The decrease of amplitude was
between 20%-80% (mean 50%). In one patient the ampli-
tude diminished to zero for a period of about 10 minutes,
not due to any surgical complication (Figure 1, patient 5).
Fifteen minutes later the value of the amplitude increased
to 0.2 mcV, without any alteration in remifentanil dose
and remained at this value till the end of the operation.
However this last value of amplitude represented a reduc-
tion of 65% from the baseline value.
Intraoperative tibial SSEP latencies were not signifi-
cantly prolonged (p = 0.774) (Figure 2). The increase in
latency was less than 10% which is the threshold to be
considered as clinically significant with the prolongation
being almost 1 msec. We also noted significant linear
time related changes in P40 amplitudes (figure 2).
Table 1: Demographic data of patients
n1 0
Age/range
mean ± SD
13-88
42.125 ± 30.7
M:F 4:6
ASA I 7
ASA II 3
Weigh (Kg) 58.5 ± 13.07
BMI (kg/m2) 23.5 ± 3.55
High (cm) 157.375 ± 8.61
Duration of anesthesia 
(minutes)
237.5 ± 63.22
Duration of operation 
(minutes)
171.5 ± 43.19
Type of surgery
Scoliosis thoracic 3
Lumbar spinal fusion 7
BMI: Body Mass Index, M:F, Male:Female, n = number of patients.Asouhidou et al. Scoliosis 2010, 5:8
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The effect of remifentanil on SSEP components in all
patients is illustrated in Figure 2.
Discussion
Neuromonitoring in the operating room allows for on-
line surveillance and early diagnosis of spinal cord dys-
function and aims to provide warning signals before an
irreversible damage has occurred. SSEP monitoring has
been shown to be feasible during administration of
inhaled or intravenous agents [3-5,11,12]. Since the use of
volatile anesthetics is not recommended when neu-
romonitoring is performing, it is essential to titrate the
doses of remifentanil during propofol anesthesia to levels
that do not significantly affect the SSEP.
Table 2: Haemodynamic data of patients receiving remifentanil 0.8 mcg/kg/min
NH R b
(beat/min)
HRr
(beat/min)
COb
(L.min-1)
COr
(L.min-1)
MAPb
(mmHg)
MAPr
(mmHg)
15 1 4 6 3 . 0 5 2 . 5 5 8 2 6 7
2 65 56 4.15 3.9 71 60
3 53 50 4.6 4.25 102 82
4 51 50 2.7 2.75 66 66
57 8 5 6 4 . 4 3 . 3 9 0 6 4
66 9 5 5 4 . 7 4 . 0 6 9 4 5
77 2 5 8 5 . 7 3 . 9 7 9 7 2
86 7 5 8 4 . 1 3 . 1 8 3 7 0
97 2 6 1 3 . 4 3 . 0 9 1 7 4
10 68 57 3.6 2.9 86 68
mean ± SD 64.6 ± 9.6 54.7 ± 4.59 4.17 ± 0.947 3.47 ± 0.631 81.9 ± 11.1 66.8 ± 9.73
Cob: Baseline Cardiac Output, Cor: Remifentanil group Cardiac Output, HRb: Heart Rate baseline, HRr: Heart Rate remifentanil group, MAPb: 
Mean Arterial Pressure baseline, MAPr: Mean Arterial Pressure remifentanil group, n = number of patients.
Figure 1 Image of amplitude decrease after 244 minutes civ remifentanil (Set 9). White arrow indicates the baseline wave (Set 2). The prolon-
gation of latency is also demonstrated.Asouhidou et al. Scoliosis 2010, 5:8
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All lipophilic agents interfering with neuron mem-
branes also interfere with subcortical conduction and
therefore cause an increase in latencies [17]. According to
some authors the application of low doses of fentanyl is
not supposed to induce the predictable changes on SSEP
latencies [10,18,19]. Strahm et al found that fentanyl pro-
duces significant changes of SSEP latency but less than
3%. The mean changes of all the amplitudes were less
than 10% compared to the preoperative values but fenta-
nyl was administered in different doses in every patient
[20]. In a study comparing amplitudes between patients
receiving either fentanyl or remifentanil, during spine
surgery, it was found that amplitudes were better pre-
served in the remifentanil group [21]. However this study
did not provide any details about the total dose of opioids
administrated intraoperatively. It has also been shown
that high doses of fentanyl decrease the amplitude by 60-
70% in patients receiving 74 mcg/kg fentanyl in induction
[22].
Remifentanil is the less lipophilic opioid compared to
fentanyl, sufentanil or alfentanil, and this makes it the
ideal opioid component of TIVA anesthesia during neu-
romonitoring. Our data demonstrate that remifentanil in
a high dose induces significant suppression in amplitude
of SSEP; in some patients even over 50%; which is the
threshold to be considered clinically significant [17]. Also
remifentanil induced prolongation of latency which how-
ever did not exceed the limit of 10%. Since remifentanil
produces changes in SSEP's components, especially in
amplitude, remifentanil should be combined with other
agents, such as esmolol, in order to titrate remifentanil to
a smaller dose. Schmidt et al demonstrated that remifen-
tanil administrated as a single agent in a dose of 0.65
mcg/kg increases the SSEP amplitude [23]. However,
when remifentanil was administered at higher doses (1
mcg/kg/min), during isoflurane anesthesia, the amplitude
was reduced [24]. A study in rats demonstrated that
remifentanil did not affect the SEP amplitude or latency
when administered alone or when it was co-administered
with propofol [14]. In this study ketamine was used which
increases the amplitude [25]. The latency was increased
approximately 1 msec which is a small but clinically sig-
nificant change according to Kalkman et al [22].
Our data also demonstrate that remifentanil has an
influence on both peak amplitude and latency of SSEP.
This fact is a useful intraoperative diagnostic tool; a
latency increase without any proportional amplitude
decrease of a given peak means a delay of activation,
without destruction, of this peak generator. As far as cor-
tical or brain-stem grey matter generators are concerned,
this implies that the dysfunctional site lies somewhere in
the white matter afferents of this structure (spinal cord,
brain-stem, cerebral hemispheres). A typical example of
such a situation is the cortical SEP alterations occurring
after spinal cord compression or ischemia. By contrast, a
pathology involving only a grey matter generator and not
its white matter afferents can cause an amplitude
decrease or the disappearance of the corresponding peak,
but there is no reason for the latency of this peak to be
considerably increased [17].
There are some limitations of this study that should be
recognized. The population study was small and future
studies should be scheduled with biger one. Also further
measurements should be performed using lower dose of
remifentanil in order to define the threshold of amplitude
changes due to remifentanil. We did not use target con-
trolled infusion (TCI) for calculating the dose of propofol
and remifentanil because TCI resulted in higher propofol
consumption and delayed recovery probably due to inac-
curate prediction of propofol effect site concentration
[26].
In summary our study demonstrates that remifentanil
in quite high doses suppresses the amplitude of SSEP
recorded from the posterior tibial nerve during spinal
surgery. The clinical implication of this finding lies in the
fact that these changes in some cases exceeded the limit
of clinical significance. This effect should be taken under
consideration in order to perform reliable neuromonitor-
ing while avoiding false positive results.
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Figure 2 Graphical plot of the amplitudes (axis y, μV) relative to 
the duration of remifentanyl infusion (axis x, sec).Asouhidou et al. Scoliosis 2010, 5:8
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